Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

admin
Pinned October 27, 2016

<> Embed

@  Email

Report

Uploaded by user
HIV researchers edge closer to a cure
<> Embed @  Email Report

HIV researchers edge closer to a cure

Jon Fingas , @jonfingas

October 02, 2016

Farooq Naeem/AFP/Getty Images

Most recent news on the fight against HIV has focused on preventative medicine and suppression, but British scientists might be inching toward an honest-to-goodness cure. A 44-year-old social worker in London appears to be completely free of the virus after undergoing an experimental “kick and kill” treatment as part of a trial. The patient first took a vaccine to help his immune system detect infected cells, and then took Vorinostat to activate dormant infected cells that normally don’t get caught. After that, it was just a matter of letting the healthy parts of the immune system kill off all the HIV, theoretically eliminating any chance of the virus coming back.

The researchers are quick to stress that there’s a long, long way to go before they’re shouting about this therapy from the rooftops. The social worker is just the first of 50 to finish the trial, and he’ll have to wait months to confirm that HIV is no longer in his system. There’s also a chance that the patient’s doses of conventional medicine are contributing to the seemingly clean bill of health. And even if everything is fine after this first experiment, the tests will carry on for another 5 years.

Still, the findings are promising. A drug cocktail like this is relatively straightforward compared to more elaborate attempts to kill or neuter HIV, such as gene editing. If it clears all the necessary hurdles (and HIV doesn’t evolve to resist the medicine), the virus won’t pose nearly as much of a threat as it has in decades past.

(27)

Pinned onto